These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8024636)

  • 1. [The effect of ranitidine and famotidine on the intragastric pH profile of healthy subjects. Randomized cross-over trial with ranitidine effervescent tablets (300 mg) versus famotidine film tablets (40 mg) ].
    Löser C; Burlage M; Fölsch UR
    Arzneimittelforschung; 1994 May; 44(5):626-9. PubMed ID: 8024636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of ranitidine effervescent tablets and magnesium hydroxide-aluminium oxide on intragastric acidity. A single-centre, randomised, open cross-over study.
    Propst A; Propst T; Judmaier G
    Arzneimittelforschung; 1996 Jun; 46(6):621-4. PubMed ID: 8767354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intragastric pH after oral administration of single doses of ranitidine effervescent tablets, omeprazole capsules and famotidine fast-dissolving tablets to fasting healthy volunteers.
    Hedenström H; Alm C; Kraft M; Grahnén A
    Aliment Pharmacol Ther; 1997 Dec; 11(6):1137-41. PubMed ID: 9663842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of ranitidine and famotidine in healthy elderly subjects: a double-blind, placebo-controlled comparison.
    Bisson C; St-Laurent M; Michaud JT; LeBel M
    Pharmacotherapy; 1993; 13(1):3-9. PubMed ID: 8437966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose famotidine and effervescent cimetidine in healthy subjects: a placebo-controlled overnight pH study.
    Reilly TG; Grimley CE; Usselmann B; Cottrell J; Mann SG; Raskin S; Nwokolo CU
    Aliment Pharmacol Ther; 1998 May; 12(5):469-74. PubMed ID: 9663728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effect of the antacid Rennie versus low-dose H2-receptor antagonists (ranitidine, famotidine) on intragastric acidity.
    Netzer P; Brabetz-Höfliger A; Bründler R; Flogerzi B; Hüsler J; Halter F
    Aliment Pharmacol Ther; 1998 Apr; 12(4):337-42. PubMed ID: 9690722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of effervescent ranitidine on gastric pH: comparison with almagate and placebo in fasting and postprandial conditions.
    Rey E; Poves-Francés C; Sánchez G; Fueyo A; Badiola C; Díaz-Rubio M
    Aliment Pharmacol Ther; 2004 Sep; 20(6):683-8. PubMed ID: 15352917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of food intake on the antisecretory effect of low-dose ranitidine and famotidine.
    Netzer P; Eschenmoser K; Halter F; Inauen W
    Aliment Pharmacol Ther; 1999 Mar; 13(3):407-12. PubMed ID: 10102975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours.
    Netzer P; Gaia C; Sandoz M; Huluk T; Gut A; Halter F; Hüsler J; Inauen W
    Am J Gastroenterol; 1999 Feb; 94(2):351-7. PubMed ID: 10022628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose famotidine and ranitidine as single post-prandial doses: a three-period placebo-controlled comparative trial.
    Reilly TG; Singh S; Cottrell J; Mann SG; Stauffer L; Walt RP
    Aliment Pharmacol Ther; 1996 Oct; 10(5):749-55. PubMed ID: 8899083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The comparative effects of single intravenous doses of omeprazole and famotidine on intragastric pH.
    Abe Y; Inamori M; Togawa J; Kikuchi T; Muramatsu K; Chiguchi G; Kawamura H; Kobayashi N; Kirikoshi H; Sakaguchi T; Takamura T; Nakajima A; Ueno N; Sekihara H
    J Gastroenterol; 2004 Jan; 39(1):21-5. PubMed ID: 14767730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric acid suppression is greater during intravenous ranitidine infusion versus bolus injections of famotidine.
    Hogan DL; McQuaid KR; Koss MA; Crombie DL; Hunter S; Metz C; Euler AR; Isenberg JI
    Aliment Pharmacol Ther; 1993 Oct; 7(5):537-41. PubMed ID: 8280822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antisecretory effect of the H2-histamine receptor antagonist ranitidine in water-soluble tablets and film-coated tablets. Results of a randomized, placebo-controlled crossover study in humans].
    Witzel L; Röhmel J
    Arzneimittelforschung; 1990 Apr; 40(4):457-9. PubMed ID: 2192716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nocturnal intragastric acidity after over-the-counter doses of famotidine, ranitidine or placebo.
    Grimley CE; Cottrell J; Mann SG; Stauffer L; Nwokolo CU
    Aliment Pharmacol Ther; 1997 Oct; 11(5):881-5. PubMed ID: 9354196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Onset of action of antisecretory drugs: beneficial effects of a rapid increase in intragastric pH in acid reflux disease.
    Pipkin GA; Mills JG
    Scand J Gastroenterol Suppl; 1999; 230():3-8. PubMed ID: 10499455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of famotidine and ranitidine in critically ill children.
    Madani S; Kauffman R; Simpson P; Lehr VT; Lai ML; Sarniak A; Tolia V
    J Clin Pharmacol; 2014 Feb; 54(2):201-5. PubMed ID: 24258773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ranitidine effervescent and famotidine wafer in the relief of episodic symptoms of gastro-oesophageal reflux disease.
    Engzelius JM; Solhaug JH; Knapstad LJ; Kjaersgaard P
    Scand J Gastroenterol; 1997 Jun; 32(6):513-8. PubMed ID: 9200279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Helicobacter pylori status on intragastric pH during administration of lafutidine or famotidine.
    Koike T; Ohara S; Sehine H; Kawamura M; Abe Y; Inomata Y; Iijima K; Imatani A; Shimosegawa T
    Hepatogastroenterology; 2007 Jun; 54(76):1280-4. PubMed ID: 17629089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of food and ranitidine on saquinavir pharmacokinetics and gastric pH in healthy volunteers.
    Kakuda TN; Falcon RW
    Pharmacotherapy; 2006 Aug; 26(8):1060-8. PubMed ID: 16863482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effervescent and standard formulations of ranitidine--a comparison of their pharmacokinetics and pharmacology.
    Watson RG; Johnston BT; Tham TC; Kersey K
    Aliment Pharmacol Ther; 1996 Dec; 10(6):913-8. PubMed ID: 8971288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.